Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0383.HK Stock Summary
In the News
0383.HK Financial details
Company Rating
Buy
Market Cap
738.49M
Income
-188.73M
Revenue
2.97B
Book val./share
2.44
Cash/share
1.13
Dividend
-
Dividend %
-
Employees
2.6K
Optionable
No
Shortable
Yes
Earnings
17 Mar 2024
P/E
-5.1
Forward P/E
-
PEG
-1.41
P/S
0.63
P/B
0.39
P/C
0.6
P/FCF
-7.21
Quick Ratio
0.53
Current Ratio
0.91
Debt / Equity
0.41
LT Debt / Equity
0.14
-
-
EPS (TTM)
-0.26
EPS next Y
-
EPS next Q
-
EPS this Y
-10.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.77%
Revenue Q/Q
8.28%
EPS Q/Q
-97.91%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-7%
ROC
-0.01%
Gross Margin
18%
Oper. Margin
-1%
Profit Margin
-8%
Payout
-
Shs Outstand
0
Shs Float
0
-
-
-
-
Target Price
-
52W Range
0.6-1.068131
52W High
-
52W Low
-
RSI
34
Rel Volume
0.23
Avg Volume
6.4K
Volume
1.5K
Perf Week
-2.86%
Perf Month
-26.88%
Perf Quarter
-
Perf Half Y
-22.73%
-
-
-
-
Beta
0.827
-
-
Volatility
0.01%, 0.04%
Prev Close
0%
Price
0.68
Change
0%
0383.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-06-30 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.63 | 1.72 | 1.66 | 2.02 | 1.97 | |
Net income per share | 0.05 | 0 | -0.15 | -0.19 | -0.17 | |
Operating cash flow per share | -0.07 | 0.28 | -0.02 | 0.3 | 0.02 | |
Free cash flow per share | -0.13 | 0.08 | -0.16 | 0.09 | -0.17 | |
Cash per share | 0.67 | 0.91 | 0.89 | 0.88 | 0.84 | |
Book value per share | 2.48 | 2.49 | 2.44 | 2.32 | 2.12 | |
Tangible book value per share | 2.44 | 2.41 | 2.37 | 2.35 | 2.16 | |
Share holders equity per share | 2.48 | 2.49 | 2.44 | 2.32 | 2.12 | |
Interest debt per share | 1.2 | 1.17 | 1.4 | 1.34 | 1.36 | |
Market cap | 2.55B | 2.26B | 1.71B | 1.01B | 805.25M | |
Enterprise value | 2.96B | 2.4B | 2.04B | 1.35B | 1.17B | |
P/E ratio | 73.02 | 1.56K | -15.3 | -7.36 | -6.52 | |
Price to sales ratio | 2.13 | 1.81 | 1.41 | 0.68 | 0.56 | |
POCF ratio | -50.28 | 11.17 | -122.16 | 4.6 | 52.34 | |
PFCF ratio | -26.79 | 38.29 | -14.96 | 15.52 | -6.57 | |
P/B Ratio | 1.4 | 1.25 | 0.96 | 0.59 | 0.52 | |
PTB ratio | 1.4 | 1.25 | 0.96 | 0.59 | 0.52 | |
EV to sales | 2.48 | 1.92 | 1.68 | 0.91 | 0.81 | |
Enterprise value over EBITDA | 179.52 | 19.6 | 19.69 | 16.11 | 17.88 | |
EV to operating cash flow | -58.42 | 11.86 | -145.29 | 6.13 | 76.07 | |
EV to free cash flow | -31.12 | 40.67 | -17.79 | 20.66 | -9.55 | |
Earnings yield | 0.01 | 0 | -0.07 | -0.14 | -0.15 | |
Free cash flow yield | -0.04 | 0.03 | -0.07 | 0.06 | -0.15 | |
Debt to equity | 0.45 | 0.44 | 0.55 | 0.54 | 0.6 | |
Debt to assets | 0.25 | 0.24 | 0.28 | 0.26 | 0.29 | |
Net debt to EBITDA | 25.02 | 1.15 | 3.13 | 4.01 | 5.58 | |
Current ratio | 0.9 | 1.01 | 0.88 | 0.73 | 0.91 | |
Interest coverage | 0.33 | 0.34 | -0.26 | -0.36 | -0.67 | |
Income quality | 0 | 139.69 | 0.13 | -1.6 | -0.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.19 | 0.19 | 0.15 | 0.18 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0 | 0 | |
Capex to operating cash flow | 0.88 | -0.71 | 7.16 | -0.7 | -8.97 | |
Capex to revenue | -0.04 | -0.11 | -0.08 | -0.1 | -0.1 | |
Capex to depreciation | 0 | -1.36 | -0.86 | -1.48 | -1.32 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.63 | 0.33 | 2.9 | 3.13 | 2.84 | |
ROIC | -0.02 | 0 | -0.01 | -0.01 | -0.02 | |
Return on tangible assets | 0.01 | 0 | -0.03 | -0.04 | -0.04 | |
Graham Net | -1.23 | -0.83 | -1.01 | -1.29 | -1.13 | |
Working capital | -125.14M | 14.54M | -132.93M | -356.38M | -97.29M | |
Tangible asset value | 1.79B | 1.75B | 1.73B | 1.72B | 1.58B | |
Net current asset value | -391.54M | -412.16M | -629.75M | -790.19M | -620.24M | |
Invested capital | 0.45 | 0.44 | 0.55 | 0.54 | 0.6 | |
Average receivables | 0 | 90.15M | 188.34M | 172.39M | 110.27M | |
Average payables | 0 | 208.66M | 171.54M | 189.56M | 195.24M | |
Average inventory | 0 | 217.09M | 180.1M | 158.57M | 229.99M | |
Days sales outstanding | 0 | 52.66 | 59 | 36.69 | 18.3 | |
Days payables outstanding | 85.63 | 65.02 | 49.78 | 64.69 | 45.73 | |
Days of inventory on hand | 93.64 | 63.68 | 56.85 | 41.36 | 89.35 | |
Receivables turnover | 0 | 6.93 | 6.19 | 9.95 | 19.95 | |
Payables turnover | 4.26 | 5.61 | 7.33 | 5.64 | 7.98 | |
Inventory turnover | 3.9 | 5.73 | 6.42 | 8.83 | 4.09 | |
ROE | 0.02 | 0 | -0.06 | -0.08 | -0.08 | |
Capex per share | -0.06 | -0.2 | -0.14 | -0.21 | -0.19 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.99 | 1.05 | 1.01 | 0.98 | 1.01 | |
Net income per share | -0.1 | -0.09 | -0.06 | -0.11 | 0 | |
Operating cash flow per share | 0.06 | 0.25 | -0.01 | 0.03 | 0.16 | |
Free cash flow per share | -0.04 | 0.13 | -0.09 | -0.08 | 0.09 | |
Cash per share | 0.85 | 0.89 | 0.81 | 0.85 | 1.13 | |
Book value per share | 2.38 | 2.35 | 2.26 | 2.15 | 2.44 | |
Tangible book value per share | 2.32 | 2.37 | 2.28 | 2.18 | 2.48 | |
Share holders equity per share | 2.38 | 2.35 | 2.26 | 2.15 | 2.44 | |
Interest debt per share | 1.42 | 1.31 | 1.3 | 1.34 | 1.04 | |
Market cap | 1.61B | 999.13M | 1.1B | 796.41M | 660.29M | |
Enterprise value | 1.99B | 1.33B | 1.47B | 1.16B | 604.63M | |
P/E ratio | -5.44 | -3.94 | -6.27 | -2.5 | -94.06 | |
Price to sales ratio | 2.25 | 1.31 | 1.51 | 1.12 | 0.86 | |
POCF ratio | 38.49 | 5.62 | -131.15 | 33.5 | 5.59 | |
PFCF ratio | -55.39 | 10.62 | -17.41 | -13.41 | 9.85 | |
P/B Ratio | 0.93 | 0.59 | 0.67 | 0.51 | 0.36 | |
PTB ratio | 0.93 | 0.59 | 0.67 | 0.51 | 0.36 | |
EV to sales | 2.8 | 1.75 | 2.02 | 1.64 | 0.79 | |
Enterprise value over EBITDA | 25.21 | 23.9 | 26.51 | 116.89 | 8.06 | |
EV to operating cash flow | 47.76 | 7.5 | -175.34 | 48.85 | 5.12 | |
EV to free cash flow | -68.74 | 14.18 | -23.28 | -19.56 | 9.02 | |
Earnings yield | -0.05 | -0.06 | -0.04 | -0.1 | 0 | |
Free cash flow yield | -0.02 | 0.09 | -0.06 | -0.07 | 0.1 | |
Debt to equity | 0.58 | 0.54 | 0.56 | 0.6 | 0.41 | |
Debt to assets | 0.29 | 0.26 | 0.27 | 0.29 | 0.22 | |
Net debt to EBITDA | 4.9 | 6 | 6.68 | 36.73 | -0.74 | |
Current ratio | 0.85 | 0.73 | 0.87 | 0.91 | 1.1 | |
Interest coverage | 0.72 | 0.31 | -0.37 | -1.01 | 0.87 | |
Income quality | -0.57 | -2.8 | 0.19 | -0.3 | -67.3 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.16 | 0.14 | 0.17 | 0.19 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.69 | -0.47 | 6.53 | -3.5 | -0.43 | |
Capex to revenue | -0.1 | -0.11 | -0.08 | -0.12 | -0.07 | |
Capex to depreciation | -1.23 | -1.78 | -0.82 | -2.21 | -0.98 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.34 | 2.15 | 1.75 | 2.31 | 0.36 | |
ROIC | 0.01 | 0 | 0 | -0.01 | 0 | |
Return on tangible assets | -0.02 | -0.02 | -0.01 | -0.02 | 0 | |
Graham Net | -1.16 | -1.31 | -1.13 | -1.14 | -0.63 | |
Working capital | -177.2M | -356.38M | -172.2M | -97.29M | 120.85M | |
Tangible asset value | 1.68B | 1.72B | 1.65B | 1.58B | 1.88B | |
Net current asset value | -674.8M | -790.19M | -561.38M | -620.24M | -283.63M | |
Invested capital | 0.58 | 0.54 | 0.56 | 0.6 | 0.41 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 26.23 | 17.5 | 20.29 | 9.16 | 12.27 | |
Days payables outstanding | 27.9 | 30.91 | 33.01 | 24.35 | 33.88 | |
Days of inventory on hand | 23.04 | 19.77 | 42.02 | 47.58 | 39.34 | |
Receivables turnover | 3.43 | 5.14 | 4.44 | 9.83 | 7.34 | |
Payables turnover | 3.23 | 2.91 | 2.73 | 3.7 | 2.66 | |
Inventory turnover | 3.91 | 4.55 | 2.14 | 1.89 | 2.29 | |
ROE | -0.04 | -0.04 | -0.03 | -0.05 | 0 | |
Capex per share | -0.1 | -0.12 | -0.08 | -0.11 | -0.07 |
0383.HK Frequently Asked Questions
What is China Medical & HealthCare Group Limited stock symbol ?
China Medical & HealthCare Group Limited is a HK stock and trading under the symbol 0383.HK
What is China Medical & HealthCare Group Limited stock quote today ?
China Medical & HealthCare Group Limited stock price is $0.68 today.
Is China Medical & HealthCare Group Limited stock public?
Yes, China Medical & HealthCare Group Limited is a publicly traded company.